{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20201218",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "65681",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/211288Orig1s003ltr.pdf",
              "date": "20201222",
              "type": "Letter"
            },
            {
              "id": "65735",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211288s003lbl.pdf",
              "date": "20201223",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20180927",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "55639",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211288s000lbl.pdf",
              "date": "20180927",
              "type": "Label"
            },
            {
              "id": "55640",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/211288Orig1s000ltr.pdf",
              "date": "20180927",
              "type": "Letter"
            },
            {
              "id": "56168",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/211288Orig1s000TOC.html",
              "date": "20181030",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA211288",
      "sponsor_name": "PFIZER",
      "openfda": {
        "application_number": [
          "NDA211288"
        ],
        "brand_name": [
          "VIZIMPRO"
        ],
        "generic_name": [
          "DACOMITINIB"
        ],
        "manufacturer_name": [
          "U.S. Pharmaceuticals",
          "Pfizer Laboratories Div Pfizer Inc"
        ],
        "product_ndc": [
          "63539-197",
          "0069-0197",
          "0069-1198",
          "0069-2299"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "DACOMITINIB"
        ],
        "rxcui": [
          "2058915",
          "2058922",
          "2058924",
          "2058926",
          "2058930",
          "2058932"
        ],
        "spl_id": [
          "b0b607d1-7a3d-40a2-bf2e-b7eb0f00f762",
          "cf672c83-c9d9-4107-bcf1-76d4106537cc"
        ],
        "spl_set_id": [
          "90da33c1-5689-4b4d-a2b5-377e1057a843",
          "4ab27d2f-e385-4e9c-b324-fa69c10b855a"
        ],
        "package_ndc": [
          "63539-197-90",
          "0069-0197-30",
          "0069-1198-30",
          "0069-2299-30"
        ],
        "unii": [
          "5092U85G58"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "VIZIMPRO",
          "active_ingredients": [
            {
              "name": "DACOMITINIB",
              "strength": "30MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "003",
          "reference_drug": "Yes",
          "brand_name": "VIZIMPRO",
          "active_ingredients": [
            {
              "name": "DACOMITINIB",
              "strength": "45MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "VIZIMPRO",
          "active_ingredients": [
            {
              "name": "DACOMITINIB",
              "strength": "15MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}